Neoantigen Cancer Vaccine(NeoCura Bio Medical Technology)

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameNeoantigen Cancer Vaccine(NeoCura Bio Medical Technology)
Drug Alias NameXH001XH-001
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNeoCura Bio Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Neocura Biotechnology Co LtdBeijing Xinhe Ruien Biomedical Technology Co LtdNeoCura Bio Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A